Quarterly report · Q1
9265.TEDINET S100PBDN
Period2022-06-01 → 2022-08-31
Filed2022-10-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.5bn | 2022-06-01 → 2022-08-31 | Cons. | Net sales |
| Revenue | ¥55.1bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.9bn | 2021-06-01 → 2021-08-31 | Cons. | Net sales |
| Operating income | ¥259m | 2022-06-01 → 2022-08-31 | Cons. | Operating income |
| Operating income | ¥202m | 2021-06-01 → 2021-08-31 | Cons. | Operating income |
| Ordinary income | ¥274m | 2022-06-01 → 2022-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥221m | 2021-06-01 → 2021-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥281m | 2022-06-01 → 2022-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥225m | 2021-06-01 → 2021-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥165m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥696m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥144m | 2021-06-01 → 2021-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥163m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss |
| Net income | ¥144m | 2021-06-01 → 2021-08-31 | Cons. | Profit loss |
| Total assets | ¥23.0bn | at 2022-08-31 | Cons. | Assets |
| Total assets | ¥24.1bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥22.2bn | at 2021-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥15.0bn | at 2022-08-31 | Cons. | Liabilities |
| Total liabilities | ¥16.1bn | at 2022-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.0bn | at 2022-08-31 | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥7.5bn | at 2021-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2022-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.0bn | at 2022-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥64.7 | 2022-06-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥272.67 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.52 | 2021-06-01 → 2021-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 34.8% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.8% | at 2021-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-06-01 → 2022-08-31 | −¥11m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-06-01 → 2022-08-31 | −¥11m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2022-08-31 | −¥233m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥71m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥71m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2022-06-01 → 2022-08-31 | ¥0 |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥5m |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥13.4bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥13.4bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-06-01 → 2022-08-31 | ¥11m |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥487m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥16m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥16m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥0 |
| —segment total | revenue | 2022-06-01 → 2022-08-31 | ¥13.5bn |
| —segment total | revenue external | 2022-06-01 → 2022-08-31 | ¥13.5bn |
| —segment total | revenue intersegment | 2022-06-01 → 2022-08-31 | ¥11m |
| —segment total | segment profit | 2022-06-01 → 2022-08-31 | ¥493m |
| Reconciling Itemsreconciling | revenue | 2021-06-01 → 2021-08-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2021-06-01 → 2021-08-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2021-06-01 → 2021-08-31 | −¥208m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2021-06-01 → 2021-08-31 | ¥72m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2021-06-01 → 2021-08-31 | ¥72m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2021-06-01 → 2021-08-31 | ¥0 |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2021-06-01 → 2021-08-31 | ¥5m |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue | 2021-06-01 → 2021-08-31 | ¥12.8bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2021-06-01 → 2021-08-31 | ¥12.8bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2021-06-01 → 2021-08-31 | ¥0 |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2021-06-01 → 2021-08-31 | ¥404m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue | 2021-06-01 → 2021-08-31 | ¥16m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue external | 2021-06-01 → 2021-08-31 | ¥16m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | segment profit | 2021-06-01 → 2021-08-31 | ¥1m |
| —segment total | revenue | 2021-06-01 → 2021-08-31 | ¥12.9bn |
| —segment total | revenue external | 2021-06-01 → 2021-08-31 | ¥12.9bn |
| —segment total | revenue intersegment | 2021-06-01 → 2021-08-31 | ¥0 |
| —segment total | segment profit | 2021-06-01 → 2021-08-31 | ¥411m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 340
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E33393-000MedicalMallReportableSegmentsMember | 0 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 493000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -233000000 | JPY |
| Operating income | CurrentYTDDuration | 259000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)福岡財務支局長 | |
| Filing date cover page | FilingDateInstant | 2022-10-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第６期第１四半期(自 2022年６月１日 至 2022年８月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)ヤマシタヘルスケアホールディングス株式会社 | |
| Company name in english cover page | FilingDateInstant | YAMASHITA HEALTH CARE HOLDINGS,INC. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 執行役員 社長 山 下 尚 登 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)福岡市博多区下川端町２番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)092－402－2922（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 執行役員 北 野 幸 文 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)福岡市博多区下川端町２番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)092－402－2922（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 執行役員 北 野 幸 文 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E33393 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 92650 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ヤマシタヘルスケアホールディングス株式会社 | |
| Filer name in english | FilingDateInstant | YAMASHITA HEALTH CARE HOLDINGS, INC. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2022-06-01 | |
| Current period end date | FilingDateInstant | 2022-08-31 | |
| Type of current period | FilingDateInstant | Q1 | |
| Current fiscal year end date | FilingDateInstant | 2023-05-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-06-01 | |
| Comparative period end date | FilingDateInstant | 2021-08-31 | |
| Previous fiscal year end date | FilingDateInstant | 2022-05-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |